To: | Eli Lilly and Company (trademarks@lilly.com) |
Subject: | U.S. Trademark Application Serial No. 88540395 - THE OVERCOME STUDY - N/A |
Sent: | October 11, 2019 01:00:02 PM |
Sent As: | ecom128@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88540395
Mark: THE OVERCOME STUDY
|
|
Correspondence Address: |
|
Applicant: Eli Lilly and Company
|
|
Reference/Docket No. N/A
Correspondence Email Address: |
|
EXAMINER’S AMENDMENT
Issue date: October 11, 2019
USPTO database searched; no conflicting marks found. The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d). 15 U.S.C. §1052(d); TMEP §704.02.
Application has been amended as shown below. As agreed to by Bruce Longbottom, applicant’s attorney on 10/11/2019, the examining attorney has amended the application as shown below. Please notify the examining attorney immediately of any objections. TMEP §707. Otherwise, no response is required. Id. In addition, applicant is advised that amendments to the goods and services are permitted only if they clarify or limit them; amendments that add to or broaden the scope of the goods and services are not permitted. 37 C.F.R. §2.71(a).
IDENTIFICATION OF GOODS AND SERVICES
The identification of goods and services is amended to read as follows:
Class 009: Downloadable electronic publications in the nature of books, manuals, magazines, journals and periodicals in the field of migraine treatment and care
Class 041: Educational services, namely, conducting classes, conferences, workshops, seminars, and training courses in the field of migraine treatment and care
Class 042: Clinical research services, namely, conducting clinical trials and studies; providing information via the
Internet and online databases in the field of medical research and clinical research trials and studies; medical research; all the aforementioned services in relation to research for migraine management, treatment and care
See TMEP §§1402.01, 1402.01(e).
DISCLAIMER STATEMENT
The following disclaimer statement is added to the record:
No claim is made to the exclusive right to use “STUDY” apart from the mark as shown.
See 15 U.S.C. §1056(a); TMEP §§1213, 1213.08(a)(i).
Hansrajh, Keton
/Keton Hansrajh/
Trademark Examining Attorney
Law Office 128
(571) 272-3396
keton.hansrajh@uspto.gov